CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Duke University Health System

As a world-class academic and health care system, Duke Health strives to transform medicine and health locally and globally through innovative scientific research, rapid translation of breakthrough discoveries, educating future clinical and scientific leaders, advocating and practicing evidence-based medicine to improve community health, and leading efforts to eliminate health inequalities.

HyHealth

HyHealth is a Toledo, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

annual reviews

annual reviews is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OEM Concepts

OEM Concepts is a Toms River, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avigen

Avigen, Inc. is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.